BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 27.20
+0.70 (2.64%)
At close: Sep 11, 2026
BioVersys AG Balance Sheet
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 69.31 | 82.51 | 26.62 | 24.38 |
Short-Term Investments | - | - | 6 | 4 |
Cash & Short-Term Investments | 69.31 | 82.51 | 32.62 | 28.38 |
Cash Growth | -24.72% | 152.94% | 14.95% | - |
Other Receivables | - | 2.44 | 1.29 | 2.07 |
Receivables | - | 2.44 | 1.29 | 2.07 |
Prepaid Expenses | 6.66 | 4.93 | 0.49 | 0.3 |
Other Current Assets | - | - | - | 2.85 |
Total Current Assets | 75.98 | 89.87 | 34.4 | 33.59 |
Property, Plant & Equipment | 0.79 | 0.77 | 0.56 | 0.58 |
Total Assets | 76.91 | 90.64 | 34.96 | 34.17 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accounts Payable | 2.63 | 2.47 | 0.71 | 1.29 |
Accrued Expenses | 3.25 | 2.87 | 3.45 | 2.2 |
Current Portion of Long-Term Debt | 0.03 | 0.03 | 2.98 | 0.03 |
Current Portion of Leases | 0.32 | 0.26 | 0.22 | 0.22 |
Current Unearned Revenue | - | 2.19 | 1.15 | 1.07 |
Other Current Liabilities | 3.44 | 1.08 | 1.17 | 4.55 |
Total Current Liabilities | 9.67 | 8.9 | 9.67 | 9.37 |
Long-Term Debt | 21.75 | 21.28 | 13.63 | 15.55 |
Long-Term Leases | 0.08 | 0.16 | 0.13 | 0.13 |
Pension & Post-Retirement Benefits | 0.57 | 0.49 | 0.84 | 0.55 |
Total Liabilities | 32.07 | 30.83 | 24.27 | 25.59 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 5.86 | 5.85 | 3.69 | 3.06 |
Additional Paid-In Capital | 155.6 | 155.6 | 87.4 | 68.77 |
Retained Earnings | -116.26 | -101.13 | -80.34 | -62.94 |
Comprehensive Income & Other | -0.36 | -0.51 | -0.07 | -0.32 |
Shareholders' Equity | 44.84 | 59.81 | 10.68 | 8.58 |
Total Liabilities & Equity | 76.91 | 90.64 | 34.96 | 34.17 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 22.18 | 21.73 | 16.97 | 15.93 |
Net Cash (Debt) | 47.14 | 60.78 | 15.65 | 12.45 |
Net Cash Growth | -36.15% | 288.25% | 25.77% | - |
Net Cash Per Share | 8.06 | 10.82 | 4.70 | 4.17 |
Filing Date Shares Outstanding | 5.85 | 5.85 | 5.82 | 2.99 |
Total Common Shares Outstanding | 5.85 | 5.85 | 0.33 | 2.99 |
Working Capital | 66.3 | 80.98 | 24.73 | 24.22 |
Book Value Per Share | 7.66 | 10.23 | 32.50 | 2.87 |
Tangible Book Value | 44.7 | 59.81 | 10.68 | 8.58 |
Tangible Book Value Per Share | 7.64 | 10.23 | 32.50 | 2.87 |
Machinery | - | 0.73 | 0.58 | 0.54 |